| Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? T Majić, TT Schmidt, J Gallinat Journal of psychopharmacology 29 (3), 241-253, 2015 | 262 | 2015 |
| Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case–control trial T Majić, H Gutzmann, A Heinz, UE Lang, MA Rapp The American journal of geriatric psychiatry 21 (11), 1052-1059, 2013 | 252 | 2013 |
| Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review S Reiche, L Hermle, S Gutwinski, H Jungaberle, P Gasser, T Majić Progress in neuro-psychopharmacology and biological psychiatry 81, 1-10, 2018 | 135 | 2018 |
| The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin T Majic, JP Pluta, T Mell, MC Aichberger, Y Treusch, H Gutzmann, ... Deutsches Ärzteblatt International 107 (18), 320, 2010 | 94 | 2010 |
| Correlates of agitation and depression in nursing home residents with dementia T Majić, JP Pluta, T Mell, Y Treusch, H Gutzmann, MA Rapp International Psychogeriatrics 24 (11), 1779-1789, 2012 | 76 | 2012 |
| Agitation in nursing home residents with dementia (VIDEANT trial): effects of a cluster-randomized, controlled, guideline implementation trial MA Rapp, T Mell, T Majic, Y Treusch, J Nordheim, M Niemann-Mirmehdi, ... Journal of the American Medical Directors Association 14 (9), 690-695, 2013 | 71 | 2013 |
| Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating BB Quednow, J Brinkmeyer, A Mobascher, M Nothnagel, F Musso, ... Proceedings of the National Academy of Sciences 109 (16), 6271-6276, 2012 | 65 | 2012 |
| Apathy in Nursing Home Residents with Dementia: Results From A Cluster-Randomized Controlled Trial☆ Y Treusch, T Majic, J Page, H Gutzmann, A Heinz, MA Rapp European Psychiatry 30 (2), 251-257, 2015 | 50 | 2015 |
| Do β-blockers cause depression? Systematic review and meta-analysis of psychiatric adverse events during β-blocker therapy TG Riemer, LE Villagomez Fuentes, EAE Algharably, MS Schäfer, ... Hypertension 77 (5), 1539-1548, 2021 | 41 | 2021 |
| Evidence-based treatment options in cannabis dependency L Walther, A Gantner, A Heinz, T Majic Deutsches Ärzteblatt International 113 (39), 653, 2016 | 39 | 2016 |
| COMT Val108/158Met genotype modulates human sensory gating T Majic, J Rentzsch, Y Gudlowski, S Ehrlich, G Juckel, T Sander, UE Lang, ... Neuroimage 55 (2), 818-824, 2011 | 35 | 2011 |
| Housing situation and healthcare for patients in a psychiatric centre in Berlin, Germany: a cross-sectional patient survey S Schreiter, S Heidrich, J Zulauf, U Saathoff, A Brückner, T Majic, ... BMJ open 9 (12), e032576, 2019 | 30 | 2019 |
| Handbuch Psychoaktive Substanzen M Von Heyden, H Jungaberle, T Majić Springer Berlin Heidelberg, 2018 | 26 | 2018 |
| Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women J Mutschler, E Abbruzzese, K Wiedemann, C Von Der Goltz, C Dinter, ... Annals of Nutrition and Metabolism 62 (4), 271-276, 2013 | 26 | 2013 |
| No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic A Bendau, L Viohl, MB Petzold, J Helbig, S Reiche, R Marek, ... International Journal of Drug Policy 102, 103582, 2022 | 25 | 2022 |
| Empirische untersuchung veränderter bewusstseinszustände: Definition, quantifizierung und forschungsperspektiven TT Schmidt, T Majić Handbuch Psychoaktive Substanzen, 153-171, 2018 | 21 | 2018 |
| Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking J Mutschler, E Abbruzzese, C Von der Goltz, C Dinter, A Mobascher, ... European addiction research 18 (5), 246-252, 2012 | 21 | 2012 |
| Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia LG Speck, J Schöner, F Bermpohl, A Heinz, J Gallinat, T Majić, C Montag Social cognitive and affective neuroscience 14 (1), 109-117, 2019 | 18 | 2019 |
| DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate status C Wirth, F Schubert, M Lautenschlager, R Bruhl, A Klar, T Majic, U E Lang, ... Current pharmaceutical biotechnology 13 (8), 1513-1521, 2012 | 16 | 2012 |
| Verhaltenssymptome bei Demenz in Pflegeeinrichtungen: Evaluation eines Tandemprojekts pflegerischer und ärztlicher Leitlinien (VIDEANT) MA Rapp, A Decker, U Klein, T Duch, Y Treusch, T Majic, A Petermann, ... Zeitschrift für Gerontopsychologie &-psychiatrie 21 (3), 205-214, 2008 | 15 | 2008 |
